Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Genmab A/S CPSE:GMAB |
110,66 B | 14,29% | 4/6 | -4,48% | 51,97% | 30,37% | DOWN |
|
Ascendis Pharma A/S NasdaqGS:ASND |
14,93 B | 144,29% | 4/6 | 91,21% | 90,39% | 21,53% | UP |
|
ALK-Abelló A/S CPSE:ALK B |
46,00 B | 32,62% | 5/6 | 55,34% | 22,51% | 22,83% | UP |
|
Zealand Pharma A/S CPSE:ZEAL |
20,96 B | 71,10% | 4/6 | -51,93% | 89,90% | 68,46% | DOWN |
|
Bavarian Nordic A/S CPSE:BAVA |
15,02 B | 21,29% | 5/6 | -21,10% | 16,97% | 41,32% | DOWN |
|
FluoGuide A/S OM:FLUO |
0,59 B | 0,00% | 2/4 | 0,00% | 0,00% | 106,01% | DOWN |
|
Evaxion A/S NasdaqCM:EVAX |
0,03 B | 0,00% | 0/0 | -47,94% | -175,86% | 143,31% | DOWN |
|
Initiator Pharma A/S OM:INIT |
0,22 B | 0,00% | 2/4 | 0,00% | 0,00% | 195,34% | DOWN |
|
Strategic Partners A/S CPSE:STRAP |
0,03 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
IO Biotech NasdaqGS:IOBT |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 39900,00% | DOWN |
|
Scandion Oncology A/S BST:8VY |
0,00 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,00% | DOWN |
|
Forward Pharma A/S OTCPK:FWPA.Y |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
